The Cann Group Ltd (ASX: CAN) share price has continued its sensational run and is rocketing higher again on Wednesday.
In afternoon trade the cannabis company’s shares are up a further 12% to 56.5 cents.
This means the Cann Group share price is now up an incredible 76% week to date.
Why is the Cann Group share price rocketing higher this week?
Investors have been fighting to get hold of the company’s shares this week after the release of an update on its debt facility.
On Monday, Cann revealed that it has received credit approval from National Australia Bank (ASX: NAB) for a $50 million secured debt facility.
These funds will be used to complete the first stage of its state-of-the-art medicinal cannabis production site near Mildura. The first stage has an estimated nine month build time, with its first product expected to be processed and released by March 2022.
Once complete, the first stage of the project will provide annual capacity to produce 12,500 kgs of dry flower equivalent.
Work is expected to be underway in February 2021, with the total project cost estimated to be $112 million. Approximately $53 million has already spent on site works and the facility superstructure. The company plans to fund the balance with the new bank loan facility and its current cash reserves.
Why is the Cann Group share price smoking the market today?
There’s no point building such an enormous facility if you don’t have licences, right?
The good news is that this afternoon the company received notice from the Australian Department of Health’s Office of Drug Control (ODC) that its existing licences (for cultivation and production of medicinal cannabis, research activities in relation to medicinal cannabis, and manufacture of medicinal cannabis products) can be extended to its new Mildura facility.
Each ODC Licence includes a condition that Cann Group must provide the ODC with evidence that an independent security assessment has been undertaken on the Mildura facility, once it has been constructed.
Cann Group’s CEO, Peter Crock, believes that in addition to having the finance in place to build the state-of-the-art facility near Mildura, having the requisite licences in place will enable the Mildura facility’s production to come on-line from a regulatory perspective.
He commented: “The variation to our licences will enable us to proceed with certainty in respect of the building of the facility and moving into cultivation, production and manufacture from the facility seamlessly. We are on track to be processing and releasing material from our Mildura facility by the end of the first quarter of calendar year 2022.”
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Brokers name 3 ASX shares to buy right now – January 15, 2021 3:02pm
- Why Advance Nanotek, Polynovo, Resolute, & Tyro shares are dropping lower – January 15, 2021 1:30pm
- Pro Medicus (ASX:PME) share price hits record high: Is it too late to invest? – January 15, 2021 1:11pm